NYSEAMERICAN:IBO Impact Biomedical (IBO) Stock Price, News & Analysis $4.25 +0.14 (+3.41%) Closing price 04:10 PM EasternExtended Trading$4.28 +0.03 (+0.59%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and TrendsSEC Filings About Impact Biomedical Stock (NYSEAMERICAN:IBO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Impact Biomedical alerts:Sign Up Key Stats Today's Range$4.13▼$4.3950-Day Range$4.11▼$7.4552-Week Range$4.06▼$10.47Volume4,014 shsAverage Volume14,890 shsMarket Capitalization$36.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Impact Biomedical, Inc. is a biotechnology and life sciences company focused on developing and commercializing biomedical technologies, pharmaceutical products and related health solutions. Its activities have included research into antiviral, antimicrobial and anti-inflammatory applications, with an emphasis on technologies intended to address infectious diseases and other public health needs. The company has described a portfolio of biomedical intellectual property and development programs rather than a broad portfolio of established commercial products. Its work has included potential therapeutics, preventive technologies and other health-related applications developed independently or through research and commercialization relationships. Impact Biomedical is publicly traded on the NYSE American under the symbol IBO. Publicly available information about its operating geographies, commercial scale and current leadership is limited, and the company appears to remain primarily focused on research, development and the potential commercialization of its technology portfolio.AI Generated. May Contain Errors. Read More Impact Biomedical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks14th Percentile Overall ScoreIBO MarketRank™: Impact Biomedical scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Impact Biomedical. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioImpact Biomedical has a P/B Ratio of 2.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.21% of the float of Impact Biomedical has been sold short.Short Interest Ratio / Days to CoverImpact Biomedical has a short interest ratio ("days to cover") of 1.98, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Impact Biomedical has recently decreased by 94.28%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldImpact Biomedical does not currently pay a dividend.Dividend GrowthImpact Biomedical does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Impact Biomedical this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Impact Biomedical to their MarketBeat watchlist in the last 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Impact Biomedical insiders have not sold or bought any company stock.Percentage Held by Insiders89.00% of the stock of Impact Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsImpact Biomedical has minimal institutional ownership at this time.Read more about Impact Biomedical's insider trading history. Receive IBO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Impact Biomedical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IBO Stock News HeadlinesImpact BioMedical advances merger with Zoar LimitedSeptember 17, 2026 | tipranks.comImpact Biomedical Files Form F-4 For Proposed Zoar Business CombinationSeptember 16, 2026 | rttnews.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.October 9 at 1:00 AM | Profits Run (Ad)Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)September 16, 2026 | finance.yahoo.comImpact Biomedical Inc. Announces Filing of F-4 Registration Statement for Proposed Business Combination with Zoar LimitedSeptember 16, 2026 | quiverquant.comQImpact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley's Limited)September 16, 2026 | globenewswire.comImpact BioMedical, Inc.: Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)September 15, 2026 | finanznachrichten.deImpact Biomedical Issues Correction On Merger Exchange Ratio As Reverse Stock Split Takes EffectSeptember 15, 2026 | rttnews.comSee More Headlines IBO Stock Analysis - Frequently Asked Questions How have IBO shares performed this year? Impact Biomedical's stock was trading at $6.5435 at the beginning of the year. Since then, IBO stock has decreased by 35.0% and is now trading at $4.25. How were Impact Biomedical's earnings last quarter? Impact Biomedical Inc. (NYSEAMERICAN:IBO) released its quarterly earnings results on Friday, August, 7th. The company reported ($0.13) earnings per share (EPS) for the quarter. The firm earned $0 million during the quarter. Impact Biomedical had a net margin of 2,254.28% and a trailing twelve-month return on equity of 8.81%. When did Impact Biomedical's stock split? Impact Biomedical's stock reverse split on Wednesday, September 23rd 2026.A 1-12.62 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, September 22nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. How do I buy shares of Impact Biomedical? Shares of IBO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/07/2026Today10/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1d) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 IBO's financial health is in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNYSEAMERICAN:IBO CIK1834105 Webwww.impactbiomedinc.com Phone(585) 232-1500FaxN/AEmployees8Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.84 million Net Margins2,254.28% Pretax Margin-5,154.29% Return on Equity8.81% Return on Assets4.49% Debt Debt-to-Equity RatioN/A Current Ratio0.16 Quick Ratio0.13 Sales & Book Value Annual Sales$30 thousand Price / Sales1,209.83 Cash FlowN/A Price / Cash FlowN/A Book Value$1.88 per share Price / Book2.26Miscellaneous Outstanding Shares8,540,000Free Float939,000Market Cap$36.30 million OptionableN/A Beta2.74 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NYSEAMERICAN:IBO) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Impact Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Impact Biomedical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
